PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
25-Sep-2025 GlobalData’s AI tool predicts pharmaceutical drug approvals with 85% success rate GlobalData
25-Sep-2025 Global Prescription Lens Market to grow 5% CAGR, driven by rising vision disorders and tech advances by 2030 MediTech-Insights
25-Sep-2025 Global Pain Management Devices Market to grow 9-10% CAGR, driven by chronic pain cases and aging population by 2029 MediTech-Insights
25-Sep-2025 Global Mice Model Market to grow 9% CAGR, driven by personalized medicine, preclinical studies by 2030 MediTech-Insights
25-Sep-2025 Global Laparoscopy Devices Market to grow 8% CAGR, driven by minimally invasive procedures and tech by 2030 MediTech-Insights
25-Sep-2025 Global Bioconjugation Market to grow 13% CAGR, driven by targeted therapeutics and biotech growth by 2030 MediTech-Insights
25-Sep-2025 Global Anesthesia Devices Market to grow 7% CAGR, driven by rising surgeries and AI integration by 2030 MediTech-Insights
25-Sep-2025 Global Spinal Imaging Market to grow 5% CAGR, driven by rising spinal disorders and AI advances by 2030 MediTech-Insights
25-Sep-2025 Alliance for Pharmacy Compounding Joins Pharmacy Podcast Network with New "Essential" Podcast ACCESS Newswire
25-Sep-2025 Jaguar Health Receives Notice of $250,000 FDA Grant to Fund Confirmatory Trial to Support FDA Approval of Canalevia for Treatment of Chemotherapy-Induced Diarrhea (CID) in Dogs ACCESS Newswire
25-Sep-2025 Medical Care Technologies Inc. Expands AI Platform to Detect Glaucoma and Cataracts ACCESS Newswire
25-Sep-2025 Global Refurbished Medical Imaging Devices Market to grow 9% CAGR, driven by cost and rising demand by 2030 MediTech-Insights
25-Sep-2025 Global Laboratory Equipment Market to grow 8% CAGR, driven by automation, AI, and rising R&D by 2030 MediTech-Insights
25-Sep-2025 Global Handheld Ultrasound Devices Market to grow 6% CAGR, driven by POC demand & home healthcare by 2030 MediTech-Insights
25-Sep-2025 Heidelberg Pharma Significantly Reduces Operating Costs and Focuses on Lead ADC Candidate HDP-101 Due to Delayed Milestone Payment Heidelberg Pharma AG
25-Sep-2025 Levicept to Present Key New Data from Phase II Trial of LEVI-04, a Novel Neurotrophin-3 Inhibitor, at ACR Convergence 2025 Levicept
25-Sep-2025 Transformational acquisition of one million litre fermentation facility Clean Food Group
25-Sep-2025 Heidelberg Pharma Significantly Reduces Operating Costs and Focuses on Lead ADC Candidate HDP-101 Due to Delayed Milestone Payment Heidelberg Pharma AG
25-Sep-2025 Half of UK doctors say age affects the ability to practise medicine, Medscape survey reveals Medscape
25-Sep-2025 ACT appointed for POLB 001 Phase 2a Trial and supply of approved bispecific antibody drug secured at no cost Poolberg Pharma